The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tsukanov V.V.

Krasnoyarsk Science Center of the Siberian — branch of the Russian Academy of Sciences, a Separate Subdivision Scientific Research Institute of Medical Problems of the North

Tonkikh Ju.L.

Krasnoyarsk Science Center of the Siberian — branch of the Russian Academy of Sciences, a Separate Subdivision Scientific Research Institute of Medical Problems of the North

Vasyutin A.V.

Krasnoyarsk Science Center of the Siberian — branch of the Russian Academy of Sciences, a Separate Subdivision Scientific Research Institute of Medical Problems of the North

Esophageal cancer morbidity, risk factors and screening

Authors:

Tsukanov V.V., Tonkikh Ju.L., Vasyutin A.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2026;28(1): 110‑115

Read: 529 times


To cite this article:

Tsukanov VV, Tonkikh JuL, Vasyutin AV. Esophageal cancer morbidity, risk factors and screening. Russian Journal of Preventive Medicine. 2026;28(1):110‑115. (In Russ.)
https://doi.org/10.17116/profmed202629011110

Recommended articles:
Current approaches to the prevention and treatment of post-thrombotic syndrome. Russian Journal of Preventive Medi­cine. 2025;(5):111-116
Risk factors of inte­rnal caro­tid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):150-155
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Premature birth and obesity: epidemiology, pathogenesis and obstetric tactics. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):29-34
Prevalence and characteristics of risk factors for cere­brovascular disease in overweight. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):118-124

References:

  1. Wu XL, Li XS, Cheng JH, et al. Oesophageal cancer-specific mortality risk and public health insurance: Prospective cohort study from China. World Journal of Gastrointestinal Oncology. 2025;17(4):103629. https://doi.org/10.4251/wjgo.v17.i4.103629
  2. Qi L, Sun M, Liu W, et al. Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data. Chinese Medical Journal. 2024;137(24):3108-3116. https://doi.org/10.1097/CM9.0000000000003420
  3. Cao W, Qin K, Li F, Chen W. Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022. Chinese Medical Journal. 2024;137(12):1407-1413. https://doi.org/10.1097/CM9.0000000000003140
  4. Zlokachestvennyye novoobrazovaniya v Rossii v 2022 godu (zabolevayemost’ i smertnost’). Pod red. Kaprina AD, Starinskogo VV, Shaxzadovoj AO, Lisichnikovoj IV. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMITS radiologii» Minzdrava Rossii; 2023. (In Russ.). https://oms66.ru/upload/iblock/52d/6u9uo6ajmjooxfl8m738lck2qzog7lza/zno_2022.pdf
  5. Lin Y, Wang HL, Fang K, et al. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030. Esophagus. 2022;19(4):560-568.  https://doi.org/10.1007/s10388-022-00927-4
  6. Morgan E, Soerjomataram I, Rumgay H, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649-658.e2.  https://doi.org/10.1053/j.gastro.2022.05.054
  7. Rumgay H, Arnold M, Laversanne M, et al. International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence. American Journal of Gastroenterology. 2021;116(5):1072-1076. https://doi.org/10.14309/ajg.0000000000001121
  8. Yang H, Wang F, Hallemeier CL, et al. Oesophageal cancer. Lancet. 2024; 404(10466):1991-2005. https://doi.org/10.1016/S0140-6736(24)02226-8
  9. Hassan C, Antonelli G, Chiu PW, et al. Position statement of the World Endoscopy Organization: Role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasiaia. Digestive Endoscopy. 2025;37(5):470-489.  https://doi.org/10.1111/den.14967
  10. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023-1075. https://doi.org/10.1016/S0140-6736(17)33326-3
  11. Sostoyaniye onkologicheskoy pomoshchi naseleniyu Rossii v 2022 godu. Pod red. Kaprina AD, Starinskogo VV, Shaxzadovoj AO, Lisichnikovoj IV. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMITS radiologii» Minzdrava Rossii; 2023. (In Russ.). https://oncology-association.ru/wp-content/uploads/2023/08/sop-2022-el.versiya_compressed.pdf
  12. Arnold M, Rutherford MJ, Bardot A, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. Lancet. Oncology. 2019;20(11): 1493-1505. https://doi.org/10.1016/S1470-2045(19)30456-5
  13. Jin W, Huang K, Ding Z, et al. Global, regional, and national burden of esophageal cancer: a systematic analysis of the Global Burden of Disease Study 2021. Biomarker Research. 2025;13(1):3.  https://doi.org/10.1186/s40364-024-00718-2
  14. Islami F, Poustchi H, Pourshams A, et al. A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. International Journal of Cancer. 2020;146(1):18-25.  https://doi.org/10.1002/ijc.32220
  15. Yu C, Tang H, Guo Y, et al. Hot Tea Consumption and Its Interactions With Alcohol and Tobacco Use on the Risk for Esophageal Cancer: A Population-Based Cohort Study. Annals of Internal Medicine. 2018;168(7):489-497.  https://doi.org/10.7326/M17-2000
  16. Liu J, Wang J, Leng Y, Lv C. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. International Journal of Cancer. 2013;133(2):473-485.  https://doi.org/10.1002/ijc.28024
  17. Lander S, Lander E, Gibson MK. Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise. Current Gastroenterology Reports. 2023;25(11): 275-279.  https://doi.org/10.1007/s11894-023-00899-0
  18. Grille VJ, Campbell S, Gibbs JF, Bauer TL. Esophageal cancer: the rise of adenocarcinoma over squamous cell carcinoma in the Asian belt. Journal of Gastrointestinal Oncology. 2021;12(Suppl 2):S339-S349. https://doi.org/10.21037/jgo-2019-gi-08
  19. Nucci D, Marino A, Realdon S, et al. Lifestyle, WCRF/AICR Recommendations, and Esophageal Adenocarcinoma Risk: A Systematic Review of the Literature. Nutrients. 2021;13(10):3525. https://doi.org/10.3390/nu13103525
  20. Gao P, Yang X, Suo C, et al. Socioeconomic status is inversely associated with esophageal squamous cell carcinoma risk: results from a population-based case-control study in China. Oncotarget. 2018;9(6):6911-6923. https://doi.org/10.18632/oncotarget.24003
  21. Xie SH, Lagergren J. Social group disparities in the incidence and prognosis of oesophageal cancer. United European Gastroenterology Journal. 2018; 6(3):343-348.  https://doi.org/10.1177/2050640617751254
  22. Zhao YX, Zhao HP, Zhao MY, et al. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma. World Journal of Gastroenterology. 2024;30(20):2638-2656. https://doi.org/10.3748/wjg.v30.i20.2638
  23. Talasila P, Hedge SG, Periasamy K, et al. Imaging in Esophageal Cancer: A Comprehensive Review. Indian Journal of Radiology and Imaging. 2024; 35(1):123-138.  https://doi.org/10.1055/s-0044-1786871
  24. Sachdeva K, Natarajan K, Iyer PG. Improving esophageal cancer screening across the globe: Translating knowledge into action. Indian Journal of Gastroenterology. 2024;43(4):705-716.  https://doi.org/10.1007/s12664-024-01543-z
  25. Li MJ, Chen R, Wang SM, Wei WW. Status and prospect of esophageal cancer screening. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2025;47(1):94-99.  https://doi.org/10.3760/cma.j.cn112152-20231024-00231
  26. Spechler SJ, Souza RF. Barrett’s esophagus. New England Journal of Medicine. 2014;371(9):836-845.  https://doi.org/10.1056/NEJMra1314704
  27. Barbiere JM, Lyratzopoulos G. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett’s esophagus: a review. Gastroenterology. 2009;137(6):1869-1876. https://doi.org/10.1053/j.gastro.2009.10.011
  28. Tachimori Y, Ozawa S, Numasaki H, et al. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14(3):189-214.  https://doi.org/10.1007/s10388-017-0578-4
  29. Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline. American Journal of Gastroenterology. 2022;117(4):559-587.  https://doi.org/10.14309/ajg.0000000000001680
  30. Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7-42.  https://doi.org/10.1136/gutjnl-2013-305372
  31. Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2017;49(2):191-198.  https://doi.org/10.1055/s-0042-122140
  32. Graham D, Lipman G, Sehgal V, Lovat LB. Monitoring the premalignant potential of Barrett’s oesophagus’. Frontline Gastroenterology. 2016;7(4):316-322.  https://doi.org/10.1136/flgastro-2016-100712
  33. Fitzgerald RC, di Pietro M, O’Donovan M, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett’s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396 (10247):333-344.  https://doi.org/10.1016/S0140-6736(20)31099-0
  34. He Z, Ke Y. Precision screening for esophageal squamous cell carcinoma in China. Chinese Journal of Cancer Research. 2020;32(6):673-682.  https://doi.org/10.21147/j.issn.1000-9604.2020.06.01
  35. He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut. 2019;68(2):198-206.  https://doi.org/10.1136/gutjnl-2017-315520
  36. He J, Chen WQ, Li ZS, et al. China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing). Zhonghua zhong liu za zhi [Chinese Journal of Oncology]. 2022;44(6):491-522.  https://doi.org/10.3760/cma.j.cn112152-20220517-00348
  37. Wei WQ, Hao CQ, Guan CT, et al. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. American Journal of Gastroenterology. 2020;115(7): 1036-1044. https://doi.org/10.14309/ajg.0000000000000640
  38. Qu JY, Li Y, Liu GQ, et al. Optimal concentration of Lugol’s solution for detecting early esophageal carcinoma: A randomized controlled trial. Journal of Gastroenterology and Hepatology. 2023;38(6):962-969.  https://doi.org/10.1111/jgh.16190
  39. Xia C, Li H, Chen W. Reduction in Esophageal Cancer Incidence and Mortality by Screening Endoscopy. Journal of Clinical Oncology. 2024;42(28): 3376-3378. https://doi.org/10.1200/JCO.24.00557
  40. Ivashkin VT, Maev IV, Trukhmanov AS, et al. Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2020;30(4):70-97. (In Russ.). https://doi.org/10.22416/1382-4376-2020-30-4-70-97
  41. Ivashkin VT, Maev IV, Trukhmanov AS, et al. Barrett’s esophagus. Pishhevod Barretta. Klinicheskie rekomendacii Rossijskoj gastroe`nterologicheskoj associacii. 2014. Accessed November 08, 2025. (In Russ.). https://www.gastro.ru/userfiles/R_Barret_14.pdf
  42. Ivashkin VT, Mayev IV, Kaprin AD, et al. Early Detection of Oncological Diseases of the Digestive System (Guidelines of the Russian Gastroenterological Association and the Russian Association of Oncologists for Primary Care Physicians). Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. 2019;29(5):53-74. (In Russ.). https://doi.org/10.22416/1382-4376-2019-29-5-53-74
  43. Mela E, Tsapralis D, Papaconstantinou D, et al. Current Role of Artificial Intelligence in the Management of Esophageal Cancer. Journal of Clinical Medicine. 2025;14(6):1845. https://doi.org/10.3390/jcm14061845

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.